MedPath

广东岭南制药有限公司

Ownership
-
Established
1991-04-12
Employees
-
Market Cap
-
Website
http://www.lingnanpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

49

NMPA:49

Drug Approvals

Compound Bismuth Aluminate Tablets

Product Name
复方铝酸铋片
Approval Number
国药准字H44024030
Approval Date
May 14, 2024
NMPA

Methotrexate for Injection

Product Name
注射用甲氨蝶呤
Approval Number
国药准字H20074246
Approval Date
May 14, 2024
NMPA

Calcium Folinate for Injection

Product Name
福能
Approval Number
国药准字H20057260
Approval Date
May 14, 2024
NMPA

Carbocysteine Tablets

Product Name
羧甲司坦片
Approval Number
国药准字H44024031
Approval Date
May 14, 2024
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H44020104
Approval Date
May 14, 2024
NMPA

Methotrexate for Injection

Product Name
注射用甲氨蝶呤
Approval Number
国药准字H20074222
Approval Date
May 14, 2024
NMPA

Aciclovir Tablets

Product Name
阿昔洛韦片
Approval Number
国药准字H20023125
Approval Date
May 14, 2024
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H44020105
Approval Date
May 14, 2024
NMPA

Methotrexate for Injection

Product Name
注射用甲氨蝶呤
Approval Number
国药准字H20054692
Approval Date
May 14, 2024
NMPA

Dacarbazine for Injection

Product Name
注射用达卡巴嗪
Approval Number
国药准字H20055753
Approval Date
May 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.